A cross-sectional exploratory survey on occurrence of triple-whammy prescription pattern in Japan
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Link
https://link.springer.com/content/pdf/10.1007/s11096-020-01088-z.pdf
Reference10 articles.
1. Loboz KK, Shenfield GM. Drug combinations and impaired renal function—the ‘triple whammy’. Br J Clin Pharmacol. 2005;59:239–43.
2. Wuarin R, Kakkassery V, Consigli A, Roquelaure D, Papanastasiou A, Schutz JS, et al. Combined topical anti-inflammatory and oral acetazolamide in the treatment of central serous chorioretinopathy. Optom Vis Sci. 2019;96:500–6.
3. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525.
4. Kunitsu Y, Isono T, Hira D, Terada T. Chronic effects on kidney function by “triple whammy” (combination of renin and angiotensin type inhibitor, diuretic drug and nonsteroidal anti-inflammatory drug). Yakugaku Zasshi. 2019;139:1457–62.
5. Japanese Society of Nephrology. Essential points from evidence-based clinical practice guidelines for chronic kidney disease 2018. Clin Exp Nephrol. 2019;23:1–15.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Counselling customers at risk of the triple whammy effect at community pharmacies – A feasibility study;Exploratory Research in Clinical and Social Pharmacy;2023-12
2. beware-of-triple-whammy;Malaysian Journal of Pharmacy;2022-06-01
3. A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims database;Expert Opinion on Drug Safety;2021-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3